|
UFM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.428000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.246400E-02 |
| Normal-vs-Stage2 |
8.521800E-01 |
| Normal-vs-Stage3 |
5.614200E-01 |
| Normal-vs-Stage4 |
3.552400E-01 |
| Stage1-vs-Stage2 |
4.213200E-01 |
| Stage1-vs-Stage3 |
5.855600E-01 |
| Stage1-vs-Stage4 |
7.613400E-01 |
| Stage2-vs-Stage3 |
8.117400E-01 |
| Stage2-vs-Stage4 |
7.507600E-01 |
| Stage3-vs-Stage4 |
9.391000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.265700E-02 |
| Normal-vs-AfricanAmerican |
4.267000E-01 |
| Normal-vs-Asian |
3.957800E-01 |
| Caucasian-vs-AfricanAmerican |
6.602400E-01 |
| Caucasian-vs-Asian |
7.589400E-01 |
| AfricanAmerican-vs-Asian |
6.578400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.542400E-02 |
| Normal-vs-Female |
4.485000E-01 |
| Male-vs-Female |
5.048600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.677400E-01 |
| Normal-vs-Extreme_Weight |
3.656400E-03 |
| Normal-vs-Obese |
5.919400E-01 |
| Normal-vs-Extreme_Obese |
3.552600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.587600E-01 |
| Normal_Weight-vs-Obese |
7.367800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.259600E-01 |
| Extreme_Weight-vs-Obese |
1.191230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.033000E-01 |
| Obese-vs-Extreme_Obese |
5.919200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.246300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.831400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.196300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.933010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.085400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.792000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.957200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.364400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.932020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.411400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.629500E-02 |
| Normal-VS-Type2 PRCC |
1.904590E-01 |
| Normal-VS-KIRP CIMP |
8.324100E-02 |
| Normal-VS-Unclassified PRCC |
8.588600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.504200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.163600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.049200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.134200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.469200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.157400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.175700E-02 |
| Normal-vs-N1 |
7.404400E-01 |
| Normal-vs-N2 |
5.418900E-04 |
| N0-vs-N1 |
1.250640E-01 |
| N0-vs-N2 |
1.937150E-01 |
| N1-vs-N2 |
1.428760E-01 |
|
|
